The Fund
OrganizationRelationship Network
| Connected Entity | Relationship Type |
Strength
(mentions)
|
Documents | Actions |
|---|---|---|---|---|
|
organization
General Partner
|
Management |
11
Very Strong
|
10 | |
|
person
A group of limited partners
|
Investment |
7
|
3 | |
|
person
General Partner
|
Management |
7
|
2 | |
|
person
Prospective Investors
|
Investment |
6
|
1 | |
|
organization
General Partner
|
Management fiduciary |
6
|
2 | |
|
organization
New Leaf
|
Management |
5
|
1 | |
|
person
Management Company
|
Management |
5
|
1 | |
|
person
Indemnitee
|
Legal representative |
5
|
1 | |
|
person
Subscriber
|
Legal representative |
5
|
1 | |
|
person
The General Partner
|
Management control |
5
|
1 | |
|
person
Recipients/Investors
|
Commercial |
5
|
1 | |
|
person
Non-U.S. Partners
|
Financial |
5
|
1 | |
|
person
U.S.
|
Financial |
5
|
1 | |
|
organization
Proskauer Rose LLP
|
Legal representative |
5
|
1 | |
|
organization
General Partner
|
Management indemnification |
5
|
1 | |
|
person
A group of limited partners
|
Investment liability |
5
|
1 | |
|
person
Non-U.S. Partners
|
Investment |
5
|
1 | |
|
person
U.S.
|
Investment fiduciary |
5
|
1 | |
|
person
Management Company
|
Service provider |
5
|
1 | |
|
person
Management Company
|
Management fiduciary |
5
|
1 | |
|
person
U.S.
|
Legal representative |
5
|
1 | |
|
organization
General Partner
|
Fiduciary managerial |
5
|
1 | |
|
organization
General Partner
|
Fiduciary |
5
|
1 | |
|
organization
Folio
|
Investment |
5
|
1 | |
|
organization
New Leaf
|
Promoter placement agent |
5
|
1 |
| Date | Event Type | Description | Location | Actions |
|---|---|---|---|---|
| N/A | N/A | Start of the period relevant to the Investment Period. | Not specified | View |
| N/A | N/A | Reference point for the 5-year investment period calculation. | Not specified | View |
| N/A | N/A | Consummation of the offering | N/A | View |
DOJ-OGR-00017586.jpg
This document is a transcript page from the trial (Case 1:20-cr-00330-PAE) involving Ghislaine Maxwell. A witness identified as 'Jane' testifies under direct examination that she received approximately $2.9 million from a victim compensation fund. She confirms that as a condition of receiving this award, she was required to dismiss her lawsuits against Maxwell and the Estate of Jeffrey Epstein. Defense attorney Ms. Menninger objects to a question regarding the impact of the jury's verdict on this award.
DOJ-OGR-00014525.jpg
Defense attorney Ms. Menninger delivers a closing argument attacking the credibility of a witness named Kate. Menninger highlights that Kate received $3.25 million from the victims' fund, sought a U visa claiming to be 'exceptional,' and admitted to emailing Epstein for decades while having no proof of contact with Ghislaine Maxwell. The defense argues Kate's memory is flawed due to substance abuse and suggestiveness, specifically challenging her claim of meeting Maxwell at 44 Kinnerton Street in 1994 to qualify for victim compensation.
HOUSE_OVERSIGHT_024061.jpg
This page is from a confidential legal document (likely a Private Placement Memorandum or Limited Partnership Agreement) describing the fee structure for an investment fund managed by New Leaf Venture Partners, L.L.C. It details a 2.5% annual management fee that decreases over time and explains how other fees collected from portfolio companies (break-up fees, monitoring fees, etc.) are used to offset the management fee. The document bears a House Oversight control number.
HOUSE_OVERSIGHT_024060.jpg
This document appears to be page 49 of a confidential legal agreement governing an investment fund, bearing a House Oversight Bates stamp. It details the financial mechanics of the fund, including a standard '2 and 20' style structure where the General Partner receives 20% of profits after investors (Partners) recoup their initial capital. It also outlines 'clawback' provisions ensuring the General Partner returns excess profits if final calculations show they were overpaid relative to the fund's total performance.
HOUSE_OVERSIGHT_024059.jpg
This document page (48) outlines specific investment restrictions for a 'Fund,' including prohibitions on uncovered options and limitations on investing in other pooled vehicles without fee adjustments. It also defines the structure and duties of an 'Advisory Board,' which is composed of Limited Partner associates selected by the General Partner to handle conflicts of interest and valuation reviews. The document bears a House Oversight Committee stamp.
HOUSE_OVERSIGHT_024058.jpg
This document appears to be page 47 of a confidential legal agreement (likely a Private Placement Memorandum or Limited Partnership Agreement) produced for the House Oversight Committee. It outlines specific terms for an investment fund, including the General Partner's required financial commitment (1.5%), the 10-year term duration, drawdown notice periods, and strict investment limitations regarding diversification and foreign investments (US/Canada focus). It references an 'Advisory Board' that holds approval power over term extensions and exceptions to investment restrictions.
HOUSE_OVERSIGHT_024007.jpg
This document is page 'iii' of a confidential investment memorandum containing standard legal disclaimers regarding risk, lack of audits, and past performance. It specifically warns investors not to rely on prior returns of related entities and notes that the investment involves a 'high degree of risk.' The text mentions 'New Leaf' in the final paragraph regarding investment performance data and bears a House Oversight Committee Bates stamp (024007).
HOUSE_OVERSIGHT_024005.jpg
This document is the 'Statement of Conditions' page (page 'i') from a Confidential Private Placement Memorandum for 'New Leaf Ventures III, L.P.' (NLV-III), a Delaware Limited Partnership. It contains standard legal disclaimers regarding the SEC, the Securities Act of 1933, and the Investment Company Act of 1940, warning investors that the fund is unregistered and high-risk. The document bears a 'CONTROL NUMBER 257 - CONFIDENTIAL' and a 'HOUSE_OVERSIGHT_024005' stamp, indicating it was part of a document production for a congressional investigation.
HOUSE_OVERSIGHT_024115.jpg
This document is page 104 of a confidential offering memorandum (Control Number 257) produced to the House Oversight Committee. It details legal restrictions and disclaimers regarding the sale of interests in 'the Fund' in Saudi Arabia, South Africa, South Korea, Spain, Sweden, and Switzerland, citing specific local financial regulations (such as CISA in Switzerland and the Financial Investment Services and Capital Markets Act in South Korea). It specifies that the fund is generally unregistered in these jurisdictions and available only to qualified/professional investors.
HOUSE_OVERSIGHT_024113.jpg
This document is page 102 of a confidential private placement memorandum (control number 257) produced for the House Oversight Committee (Bates stamp 024113). It contains legal disclaimers and regulatory compliance statements regarding the marketing of 'The Fund' to professional investors in France, Germany, Hong Kong, and Iceland, explicitly stating it is not a public offering.
HOUSE_OVERSIGHT_024112.jpg
This document is page 101 of a confidential offering memorandum detailing legal disclaimers and regulatory compliance for an investment fund across multiple jurisdictions (Brazil, Columbia, Denmark, Finland). It specifically notes that the entity 'New Leaf' is involved in the transaction, stating that recipients contacted New Leaf on their own initiative. The footer indicates this document is part of a House Oversight Committee investigation (CONTROL NUMBER 257).
HOUSE_OVERSIGHT_024099.jpg
This document is page 88 of a confidential offering memorandum (stamped House Oversight) outlining 'Additional Information' for an investment fund. It designates Proskauer Rose LLP as legal counsel and KPMG LLP as accountants for the fund. It directs all inquiries regarding the offering to Ron Hunt at New Leaf Venture Partners, L.L.C. in New York City.
HOUSE_OVERSIGHT_024098.jpg
This document page appears to be a legal disclosure or risk factor description regarding 'pay-to-play' laws and SEC regulations. It outlines the risks associated with investment advisers making political contributions to elected officials, noting that such actions could prohibit the adviser from receiving compensation for two years and negatively impact 'the Fund.' The document bears a House Oversight Bates stamp, indicating it is part of a congressional investigation.
HOUSE_OVERSIGHT_024097.jpg
This document is page 86 of a confidential legal document, likely a Private Placement Memorandum, stamped with 'HOUSE_OVERSIGHT_024097'. It details compliance matters, specifically stating that the Management Company and General Partner are not registered under the Investment Advisers Act of 1940. It outlines strict Anti-Money Laundering (AML) requirements, including verifying investor identities and ensuring funds are not derived from illegal activities or associated with OFAC-sanctioned entities. It also briefly introduces 'Pay-to-Play' laws in the context of recent scandals involving money managers.
HOUSE_OVERSIGHT_024096.jpg
This is page 85 of a confidential Private Placement Memorandum (PPM) obtained by the House Oversight Committee (Bates stamp HOUSE_OVERSIGHT_024096). It details legal and regulatory considerations for an unnamed 'Fund,' specifically focusing on exemptions from the Securities Act of 1933 and the Investment Company Act of 1940. Crucially, it discloses that the General Partner is not registered as a broker-dealer with the NASD or under the Exchange Act.
HOUSE_OVERSIGHT_024095.jpg
This document page (labeled confidential, page 84) outlines the regulatory compliance framework for 'the Fund' regarding ERISA (Employee Retirement Income Security Act). It details the General Partner's authority to restrict 'benefit plan investors' to avoid the Fund's assets being classified as 'plan assets,' and advises prospective investors, including governmental and church plans, to consult legal counsel regarding liability and reporting requirements (specifically IRS Form 5500). The document bears a House Oversight Committee Bates stamp.
HOUSE_OVERSIGHT_024094.jpg
This document appears to be page 83 of a confidential legal or financial memorandum (likely an offering document) related to a specific investment fund. It details the regulatory compliance strategies regarding ERISA (Employee Retirement Income Security Act), specifically explaining how the Fund intends to qualify as a 'Venture Capital Operating Company' (VCOC) or limit 'benefit plan investor' participation to stay under the 25% threshold, thereby avoiding the classification of its assets as 'plan assets.' The document bears a House Oversight Bates stamp, indicating it was obtained during a congressional investigation.
HOUSE_OVERSIGHT_024093.jpg
This document appears to be page 82 of a confidential offering memorandum (PPM) for an investment fund. It contains standard legal disclaimers regarding U.S. tax consequences and the necessity for investors to consult their own tax advisors. The page also introduces 'Certain ERISA Considerations,' outlining the regulatory environment (Department of Labor) and fiduciary duties for employee benefit plans considering investment in the Fund. The document bears a 'HOUSE_OVERSIGHT' Bates stamp and a specific control number (257), indicating it was part of a Congressional investigation.
HOUSE_OVERSIGHT_024092.jpg
This document is page 81 of a confidential legal document, likely a Private Placement Memorandum (PPM) for an investment fund. It details tax consequences for investors, specifically focusing on currency conversion issues for Non-U.S. Partners, withholding taxes (FATCA) on foreign entities, and state/local tax liabilities. The document bears a 'HOUSE_OVERSIGHT' stamp, indicating it was part of a congressional investigation.
HOUSE_OVERSIGHT_024091.jpg
This document is page 80 of a confidential financial or legal document, likely an Offering Memorandum, marked with a House Oversight bates stamp. It details U.S. federal income tax considerations for 'Non-U.S. Partners' investing in 'the Fund,' specifically covering withholding taxes, branch profits tax, tax treaties, and capital gains rules regarding U.S. sources and real property holding corporations (USRPHC).
HOUSE_OVERSIGHT_024090.jpg
This document is page 79 of a confidential legal memorandum, likely a Private Placement Memorandum (PPM) for an investment fund. It details U.S. tax reporting requirements for U.S. partners owning non-U.S. entities and outlines the 'General Partner's' obligation to structure the fund's activities to avoid being classified as a U.S. trade or business, thereby limiting tax liabilities for non-U.S. partners. The document bears a House Oversight Committee stamp, indicating it is part of a congressional investigation.
HOUSE_OVERSIGHT_024089.jpg
Page 78 of a confidential financial offering document (likely a PPM) describing U.S. federal income tax consequences for investors ('Partners') in 'The Fund.' The text details complex regulations regarding Controlled Foreign Corporations (CFCs), the applicability of U.S. Foreign Tax Credits for taxes paid in other jurisdictions, and the tax treatment of Foreign Currency gains and losses. The document bears a 'HOUSE_OVERSIGHT' Bates stamp, indicating it was part of a congressional investigation.
HOUSE_OVERSIGHT_024088.jpg
This document is page 77 of a confidential financial disclosure (likely a Private Placement Memorandum) bearing a House Oversight Bates stamp. It details complex U.S. tax compliance rules for investors ('U.S. Partners') in 'The Fund,' specifically regarding Passive Foreign Investment Companies (PFIC) and Controlled Foreign Corporations (CFC) under Sections 951 through 957 of the Tax Code. It warns investors of potential tax liabilities on earnings from non-U.S. corporations even if those earnings are not distributed.
HOUSE_OVERSIGHT_024087.jpg
This document is page 76 of a confidential legal or financial offering memorandum (marked with a House Oversight Bates stamp). It details the tax implications for U.S. partners regarding investments in Passive Foreign Investment Companies (PFICs) and Controlled Foreign Corporations (CFCs). It explains the IRS criteria for PFIC classification, the taxation of excess distributions, and the option for a Qualified Electing Fund (QEF) election to mitigate certain tax liabilities.
HOUSE_OVERSIGHT_024086.jpg
This document is page 75 of a confidential offering memorandum or partnership agreement, marked with a House Oversight control number. It details the tax implications for both tax-exempt and taxable U.S. partners in an investment fund, specifically addressing Unrelated Business Taxable Income (UBTI), limitations on deductions (Section 67 and 68 of the Code), and the 3.8% surtax on unearned income (Section 1411). It outlines the obligations of the General Partner to mitigate tax liabilities for investors.
Discussion 0
No comments yet
Be the first to share your thoughts on this epstein entity